HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marc N Potenza Selected Research

Disruptive, Impulse Control, and Conduct Disorders (Kleptomania)

5/2013A targeted review of the neurobiology and genetics of behavioural addictions: an emerging area of research.
3/2013A double-blind, placebo-controlled trial of topiramate for pathological gambling.
10/2012Compulsive features in behavioural addictions: the case of pathological gambling.
12/2010Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study.
5/2010Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.
5/2008[The neurobiology of impulse control disorders].
1/2008The neurobiology and genetics of impulse control disorders: relationships to drug addictions.
1/2008Long-term follow-up of impulse control disorders in Parkinson's disease.
12/2007Drug Insight: impulse control disorders and dopamine therapies in Parkinson's disease.
7/2006Association of dopamine agonist use with impulse control disorders in Parkinson disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marc N Potenza Research Topics

Disease

57Gambling (Pathological Gambling)
09/2022 - 09/2002
31Substance-Related Disorders (Drug Abuse)
04/2022 - 01/2005
14Cocaine-Related Disorders (Cocaine Addiction)
01/2019 - 03/2006
12Alcoholism (Alcohol Abuse)
01/2022 - 11/2008
10Disruptive, Impulse Control, and Conduct Disorders (Kleptomania)
05/2013 - 07/2006
9Obesity
01/2022 - 02/2010
8Parkinson Disease (Parkinson's Disease)
03/2016 - 07/2006
5COVID-19
01/2021 - 01/2020
5Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
12/2020 - 01/2009
4Mental Disorders (Mental Disorder)
01/2022 - 03/2004
4Wounds and Injuries (Trauma)
12/2020 - 08/2014
4Food Addiction
01/2017 - 04/2015
3Tobacco Use Disorder (Nicotine Dependence)
01/2022 - 11/2013
3Pain (Aches)
01/2021 - 01/2017
2Mood Disorders (Mood Disorder)
01/2022 - 07/2019
2Overweight
01/2022 - 02/2011
2Marijuana Use
12/2020 - 03/2019
2Bulimia (Binge Eating)
04/2016 - 03/2014
2Personality Disorders (Personality Disorder)
08/2014 - 08/2012
2Antisocial Personality Disorder (Antisocial Personality)
05/2011 - 01/2011
1Hypertension (High Blood Pressure)
03/2022
1Heart Diseases (Heart Disease)
03/2022
1Major Depressive Disorder (Major Depressive Disorders)
09/2021
1Genetic Risk Score
01/2021
1Binge-Eating Disorder (Binge Eating Disorder)
01/2021
1Medically Unexplained Symptoms
11/2020
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
06/2020
1Substance Withdrawal Syndrome (Withdrawal Symptoms)
01/2019
1Disease Progression
10/2017
1Hypersensitivity (Allergy)
01/2017
1Compulsive Sexual Behavior Disorder
09/2016
1Drug-Related Side Effects and Adverse Reactions
03/2016
1Excoriation Disorder
01/2016
1Trichotillomania
01/2016
1Hyperphagia (Overeating)
04/2015
1Cognitive Dysfunction
03/2015
1Marijuana Abuse (Cannabis Abuse)
07/2014

Drug/Important Bio-Agent (IBA)

32Pharmaceutical PreparationsIBA
09/2022 - 01/2003
28Cocaine (Cocaine HCl)IBA
09/2021 - 10/2004
12Biological ProductsIBA
01/2022 - 09/2002
10Dopamine (Intropin)FDA LinkGeneric
01/2021 - 12/2007
8Neurotransmitter Agents (Neurotransmitter)IBA
01/2020 - 05/2008
8Dopamine Agonists (Dopamine Agonist)IBA
03/2016 - 07/2006
5Narcotic Antagonists (Opioid Antagonists)IBA
02/2020 - 01/2003
5Serotonin (5 Hydroxytryptamine)IBA
01/2020 - 01/2004
4Immunoglobulin D (IgD)IBA
01/2022 - 01/2017
4Opioid Analgesics (Opioids)IBA
01/2021 - 08/2013
4Methadone (Dolophine)FDA LinkGeneric
01/2021 - 09/2016
4Naltrexone (ReVia)FDA LinkGeneric
02/2020 - 11/2008
4NicotineFDA Link
01/2014 - 03/2009
3Methamphetamine (Desoxyn)FDA LinkGeneric
01/2022 - 03/2019
3Illicit Drugs (Recreational Drugs)IBA
01/2021 - 11/2013
3CannabinoidsIBA
12/2020 - 12/2012
3Heroin (Diamorphine)IBA
12/2020 - 02/2010
3SmokeIBA
11/2020 - 06/2008
3Paroxetine (Paxil)FDA LinkGeneric
09/2016 - 07/2003
3nalmefene (Revex)FDA Link
10/2010 - 02/2006
2Insulin (Novolin)FDA Link
03/2022 - 02/2013
2amsonic acid (DAS)IBA
01/2020 - 03/2016
2Crack CocaineIBA
03/2019 - 01/2009
2Disulfiram (Antabuse)FDA Link
11/2017 - 01/2017
2Opiate AlkaloidsIBA
01/2017 - 11/2008
2Caffeine (No Doz)FDA LinkGeneric
12/2015 - 01/2014
2CB1 Cannabinoid Receptor (CB1 Receptor)IBA
10/2014 - 12/2012
2Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
06/2014 - 01/2003
2Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA
02/2014 - 11/2013
2Glutamic Acid (Glutamate)FDA Link
08/2013 - 12/2010
25-HT1B Serotonin ReceptorIBA
03/2013 - 05/2010
2Antipsychotic Agents (Antipsychotics)IBA
01/2004 - 01/2003
1Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
04/2022
1Phosphotransferases (Kinase)IBA
01/2022
1saracatinibIBA
01/2022
1Glycoproteins (Glycoprotein)IBA
01/2022
1naxagolideIBA
01/2021
1COVID-19 VaccinesIBA
01/2021
1gamma-Aminobutyric Acid (GABA)IBA
01/2021
1SuspensionsIBA
01/2021
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
01/2021
1Amphetamine (Amfetamine)FDA LinkGeneric
11/2020
1N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA
03/2019
1BenzodiazepinesIBA
01/2019
1Biomarkers (Surrogate Marker)IBA
01/2018
1Oxytocin (Pitocin)FDA LinkGeneric
01/2017
1SugarsIBA
01/2017
1CarbohydratesIBA
01/2017
1GlucocorticoidsIBA
01/2017
1Indicators and Reagents (Reagents)IBA
09/2016
1Dopamine beta-HydroxylaseIBA
06/2016
1Biological FactorsIBA
08/2015
1SolutionsIBA
11/2014
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
10/2014
1ORALIT (ORS)IBA
08/2014

Therapy/Procedure

15Therapeutics
01/2021 - 12/2007
8Drug Therapy (Chemotherapy)
01/2021 - 07/2006
2Duration of Therapy
01/2021 - 01/2003
2Aftercare (After-Treatment)
01/2014 - 05/2012
1Transcranial Direct Current Stimulation
01/2021
1Pain Management
01/2017
1Cognitive Training
09/2016
1Medication Errors (Medication Error)
03/2016